retatrutide side effects phase 2 trial Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized 2a Retatrutide vs Tirzepatide (2026): Differences

The refined models exhibited good model-density fitting and model geometry (see Supplementary information, Table S1 for data and model refinement statistics)

A systematic review of drug-drug interactions with GLP-1RAs found that most co-administered oral drugs did not experience clinically significant changes in total exposure (AUC), although reduced peak concentrations (Cmax) and delayed time to peak (Tmax) were commonly observed, particularly for drugs with high solubility and permeability (108)

GLP-1 receptor agonists and pancreatic cancer risk in drug-naive patients with type 2 diabetes

2023 Aug 5;402(10400):472-483.

Short-acting GLP-1 medications (exenatide immediate-release, lixisenatide) must be administered within 60 minutes before meals for optimal post-prandial glucose control